The US Federal Trade Commission has been highly successful in blocking mergers in court over the past several years, but it recently lost its challenge to the Evonik/PeroxyChem merger. Jenn Mellott speaks with Eric Mahr, Andrew Ewalt, and Laura Onken, members of the Freshfields antitrust team who worked on the litigation, about the case and what businesses should take away from this significant win against the FTC.
Essential Antitrust #6: COVID-19 and M&A – merger control during the pandemic
WorkLife 2.0: Oversight and compliance challenges
International arbitration #4: data protection and cyber security in arbitration proceedings
Essential Antitrust #5: the politics of global M&A – navigating foreign investment controls
WorkLife 2.0: office life – but not as we know it
Worklife 2.0: exploring the new normal for the workforce
The challenges and opportunities of payments deals
Tax matters: what the UK’s 2020 Budget means for business
FS market conduct #2: UK FCA enforcement themes and what’s coming up
Essential Antitrust #3: US spotlight on vertical mergers
Sanctions and international trade #2: 2020 trends to watch
Global investigations #5: managing conduct risk – the evolving approach
TechConnect - Europe’s approach to regulating artificial intelligence
Essential Antitrust #2: Brexit and the interaction between the EU and UK competition regimes
Essential Antitrust #1: global antitrust in 2020
Sanctions and international trade #1: sanctions trends and developments
Stonewall’s Global Workplace Briefings
International arbitration #3: global developments in ISDS
International arbitration #2: Achmea and intra-EU BITs
Create your
podcast in
minutes
It is Free
The Commercial Edge: Unleash the Power of People
The emPOWERed Half Hour
U.S Property Podcast
Aligned Money Show
Gorse Culture PODcast : The H.R. Detective Agency!
The Ramsey Show
Planet Money